Product Name: DLEC1 Antibody
Species Reactivity: Human
Tested Applications: WB
Applications: For WB starting dilution is: 1:1000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 196 kDa
Immunogen: This DLEC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 263-292 amino acids from the N-terminal region of human DLEC1.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 1204313-51-8
Product: Icotinib (Hydrochloride)
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration:
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Deleted in lung and esophageal cancer protein 1, Deleted in lung cancer protein 1, DLC-1, DLEC1 {ECO:0000312|EMBL:BAA776241}
Accession NO.: Q9Y238
Protein Ino: 296434480
Official Symbol: DLEC1
Geneid: 9940
Background: This gene contains 37 exons, spans approximately 59-kb,and is located in the 3p22-p21.3 chromosomal segment that iscommonly deleted in various carcinomas. Several alternativelyspliced transcripts have been observed that contain disruptedcoding regions and likely encode nonfunctional proteins. Aberranttranscription of this gene may be involved in carcinogenesis of thelung, esophagus, and kidney.
PubMed ID:http://aac.asm.org/content/38/9/1953.abstract
